BMI1 and neoplasm: The expression of stem cell markers such as ALDH1, BMI-1, CD44, Nanog, and SOX2 is well-investigated for other tumour entities, and has shown promising results as prognostic parameters with potential as a target for cancer treatment [43, 44].